This inventor holds 4 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Levo Therapeutics, Inc., Acadia Pharmaceuticals Inc.. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2023
Title: Christopher Bryant: A Pioneer in Carbetocin Drug Development
Introduction
Christopher Bryant, based in Burr Ridge, Illinois, is an innovative inventor with a focus on advancements in pharmaceutical formulations. He holds four patents that contribute significantly to the field of drug development, specifically targeting improvements in carbetocin drug products.
Latest Patents
Bryant's latest patents revolve around an agitation process for preparing carbetocin drug products. His first patent details a method for producing an improved carbetocin formulation by agitating an aqueous solution of carbetocin along with excipients. This process initiates the formation of aggregate-forming solids, which are then filtered out to ensure that the final drug product is substantially free from these aggregates. This innovation is particularly relevant for treating neurodevelopmental disorders, such as Prader-Willi syndrome. His broader patent claims also highlight the benefits of content uniformity in carbetocin over extended periods, including post freeze-thaw cycles, ultimately enhancing patient compliance and convenience.
Career Highlights
Throughout his career, Christopher Bryant has worked with notable companies in the pharmaceutical industry, including Levo Therapeutics, Inc. and Acadia Pharmaceuticals Inc. His contributions have had a lasting impact on the formulation processes for drug development, particularly those involving carbetocin.
Collaborations
Bryant has collaborated with talented individuals in the field, including Mark Cornell Manning and Ryan Erik Holcomb. These partnerships have allowed him to enhance his innovative approaches and further the development of his patent claims.
Conclusion
Christopher Bryant's work in the pharmaceutical industry, particularly with carbetocin formulations, showcases his commitment to advancing medical treatments. With a portfolio of innovative patents and collaborative efforts, he continues to play a significant role in improving drug manufacturing processes for better patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile